82VS is a venture capital firm. Based in Boston, Massachusetts, United States. The known portfolio is one company, Cantai Therapeutics.
Is 82VS a fit for your startup?
Paste your website. AI checks the fit and scores every other investor too.
Investment focus
- Stage
- Seed
- Sector
- Healthcare
Who to pitch at 82VS
82VS portfolio company (1)
- Cantai Therapeutics
Co-investors
Funds that share portfolio companies with 82VS.
Similar funds
Showing 20 of 100
About 82VS
The firm's listing covers sector Healthcare, and focus areas Biotech and Drug Discovery; listed stage is Seed.
The contacts to approach at 82VS are Errik Anderson (Managing Partner) and Victor Stone (General Partner).
Across the known portfolio, 2 co-investors appear alongside 82VS, including Tellus Bioventures and Agent Capital.
Frequently asked questions
What is 82VS?
82VS is a venture capital firm based in Boston, Massachusetts, United States, with a known portfolio of one company. The portfolio comes from public investment records rather than from the firm, so deals that never surfaced publicly are not in it.
What does 82VS invest in?
Listed sectors include Healthcare; listed focus areas include Biotech and Drug Discovery. Those tags come from the portfolio attached to the firm, so they describe what has been backed rather than a stated mandate for what comes next.
What stage does 82VS invest at?
82VS is listed for Seed rounds in the database. Check that against your own round before reaching out: stage mismatch is the most common reason a well matched sector still goes nowhere.
Who should I pitch at 82VS?
Both people on file at 82VS are listed as contacts for the firm, each with their own profile page.
How do I contact 82VS?
Any email address on file for the firm is masked on this page and readable inside RaiseHunt after you create an account. The 2 people attached to the firm have their own pages, each showing whether an address is on file for them.
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
Data: RaiseHunt investor dataset · Snapshot 5 September 2026 · How this data is built · Report a correction or request removal